On-site fabrication of injectable I-131-labeled microgels for local radiotherapy
On-site fabrication of injectable 131I-labeled microgels for local radiotherapy
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q1
- 저널
- JOURNAL OF CONTROLLED RELEASE322 · pp.337 · 2020
- 피인용
- Web of Science 25Scopus 25
- FWCI (Scopus)
- 0
- JCR IF
- JCR 2019 7.727
- ISSN
- 0168-3659
저자
- 김소담제1저자Department of Biomaterials Science, Pusan National University, Miryang 50463, Republic of Korea
- 임상구Department of Biomaterials Science, Pusan National University, Miryang 50463, Republic of Korea
- 아지시 찬드라세카란Department of Biomaterials Science, Pusan National University, Miryang 50463, Republic of Korea
- 성금용Department of Biomaterials Science, Pusan National University, Miryang 50463, Republic of Korea
- 이태욱Department of Biomaterials Science, Pusan National University, Miryang 50463, Republic of Korea
- Kim, ByeongyeonDepartment of Biomedical Engineering, Hanyang University, Seoul 04763, Republic of Korea
- 김근영교신저자Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan 49241, Republic of Korea
- Choi, SungyoungDepartment of Biomedical Engineering, Hanyang University, Seoul 04763, Republic of Korea
- 양승윤Department of Biomaterials Science, Pusan National University, Miryang 50463, Republic of Korea
초록
Nuclear medicine is a routine but essential clinical option for diagnostic imaging and disease treatment. Encapsulating radioisotopes in injectable biodegradable hydrogels is ideal for localizing radiation sources to target tissues or organs to achieve long-term, low-dose radiotherapy. However, difficulties in the on-site production of radioactive gels upon treatment and the unpredictable radiation level at the target region are major obstacles to their clinical use. In this study, we bypassed these limitations by developing locally injectable hydrogel microparticles based on I-131-labeled photo-crosslinkable hyaluronic acid (HA) and a microfluidic highthroughput droplet generator. This approach enabled rapid on-site production of injectable, radioactive, biodegradable (IRB) HA microgels, thus allowing their immediate therapeutic application with improved local retention and predictable radioactivity. We demonstrated the clinical utility of this comprehensive approach by preparing IRB HA microgels within 15 min and localizing them to the target tissue (rat muscle) with minimal offtarget biodistribution and in vivo radioactivity that extended beyond 3 weeks.
키워드
Injectable drug delivery systemRadiotherapyHyaluronic acidI-131Hydrogel microparticleCENTRIFUGAL STEP EMULSIFICATIONIN-SITUSEED IMPLANTATIONRADIATIONHYDROGELTHERAPYI-125BIODISTRIBUTIONEMULSIONSDELIVERY131I
식별자
- Scopus EID
- 2-s2.0-85082723754
- WoS UID
- 000537134400001



로그인
연구물 목록으로